8N Similar outcome in a randomized phase III trial...

8N Similar outcome in a randomized phase III trial comparing docetaxel versus vinorelbine both combined with trastuzumab as first line treatment for metastatic or locally advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer

M. Andersson, E. Lidbrink, E. Wist, K. Enevoldsen, A.B. Jensen, P.G. Sørensen, K. Bjerre, S. Møller, J. Bergh, S.T. Langkjer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
8
Year:
2010
Language:
english
DOI:
10.1016/s1359-6349(10)70035-5
File:
PDF, 43 KB
english, 2010
Conversion to is in progress
Conversion to is failed